Kalia J Metabolic Labeling-Based Chemoproteomics Establishes Choline Metabolites as Protein Function Modulators
Still on the menu, but hydration becomes a full-time job
Having cleared the hurdle as a treatment for diabetes, the FDA then approved semaglutide, marketed as Wegovy, for obesity in 2021, and then in Europe the following year
Authors Note: The structure of this letter is going to be a bit different from our usual, more narrative style at StayCurious Metabolism
Blocking FOXO4, which inhibits the activation of P53, causes senescent cells to undergo apoptosis by P53 activation, without affecting healthy cells around them, and has anti-aging effects which may have potential applications in the treatment of numerous age-related diseases, as well as an adjunct to treatment for certain forms of cancer
Adverse effects of growth hormone replacement therapy in children